Dr. Baron is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
12863 Baywind Pt
San Diego, CA 92130Phone+1 858-720-8502Fax+1 858-344-2816
Education & Training
Medical College of Georgia at Augusta UniversityClass of 1978, MD
Certifications & Licensure
CA State Medical License 2001 - 2025
CO State Medical License 1981 - 1983- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Publications & Presentations
PubMed
- 86 citationsInsulin resistance in the vasculatureKieren J. Mather, Helmut O. Steinberg, Alain D. Baron
The Journal of Clinical Investigation. 2013-03-01 - 139 citationsAntiobesity Effects of the β-Cell Hormone Amylin in Diet-Induced Obese Rats: Effects on Food Intake, Body Weight, Composition, Energy Expenditure, and Gene ExpressionJonathan D. Roth, Heather Hughes, Eric S. Kendall, Alain D. Baron, Christen M. Anderson
Endocrinology. 2006-12-01 - 322 citationsLeptin responsiveness restored by amylin agonism in diet-induced obesity: Evidence from nonclinical and clinical studiesJonathan D. Roth, Barbara L. Roland, Rebecca L. Cole, James L. Trevaskis, Christian Weyer
Proceedings of the National Academy of Sciences of the United States of America. 2008-05-20
Press Mentions
Escient Pharmaceuticals Announces Positive Results from Phase 1 Study of EP547, an MrgprX4-Targeted Oral Therapy for Cholestatic and Uremic PruritusJuly 14th, 2021- Escient Pharmaceuticals Names Svetlana Makhni as Chief Financial OfficerMay 3rd, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
